The Chinese Solar Machine Layer by Layer Fire in the Library The Mystery Behind Anesthesia
In stitches: Hospital sutures coated with a bacteria-fighting virus (shown above) effectively killed off 96 percent of an antibiotic-resistant bacteria in culture. Researchers used these same sutures to sew up bacterially infected wounds in live rats. The treated stitches prevented infection from flaring up, while rats with untreated sutures developed large sores and inflammation.
University of Strathclyde
In the fight against infection, viruses may take up where antibiotics leave off.
Hospitals are fertile ground for infectious bacteria, which can spread rapidly across countertops, stethoscopes, and catheters. These "superbugs" infect up to 1.2 million patients a year in the United States, according to a 2007 report from the Association for Professionals in Infection Control and Epidemiology, and they're quick to evolve defenses against even the most powerful antibiotics.
Now scientists in Scotland have come up with an alternative to antibiotics, which may effectively stop bacteria in its tracks. Janice Spencer and a team of researchers at the University of Strathclyde are developing nylon sutures coated with bacteriophages--viruses, found naturally in water, that eat bacteria while leaving human cells intact. New research by the Scottish team found that phage-coated sutures effectively stemmed infection in live rats.
Bacteriophages are not a recent discovery. During World War II, Russian doctors used cocktails of these viruses to treat soldiers infected with bacteria such as dysentery and gangrene. However, researchers soon turned their attention from bacteriophages to the rapidly rising field of antibiotics, developing new classes of antibiotics to combat ever-more-resistant strains of bacteria.
"Now we're coming to the end of the usefulness of antibiotics," says Spencer. "It takes time to get new classes of antibiotics onto the market, whereas bacteriophages can be easily isolated from environmental sources such as sewage water."
In water, these natural-born killers are extremely effective at eating up bacteria. The virus binds to bacteria and injects its DNA, replicating within its host until it reaches capacity, whereupon it bursts out, killing the bacteria in the process.
Obtaining bacteriophage-laden water samples is easy, says Spencer. The challenge is in keeping virus molecules active out of water. In dry environments, the virus's proteins tend to fall apart in a matter of hours, rendering them ineffective against bacteria. Spencer and her colleagues isolated bacteriophages from water samples and developed a novel method to keep them active.
The team chemically bound bacteriophages to microscopic polymer beads by first breaking the surface of the polymer. Then the researchers added a linker molecule to the polymer's surface, which in turn binds to bacteriophages and keeps them from falling apart. To test the virus's virulence, the team first made small incisions in live rats, then infected them with Methicillin-Resistant Staphylococcus Aureus (MRSA), one of the most resistant strains of bacteria found in hospitals. Half of the rats were stitched up with sutures that were coated with polymer-bound bacteriophages. The other rats were closed up with untreated sutures.
Spencer and her colleagues found that the wounds dressed with the treated sutures appeared to have no infection, while those stitched with regular sutures became inflamed, with large sores and "abundant pus."
As stated in the article it mentioned that they are having problems mainly because the virus's protein starts falling apart when out of the water. Couldn't you use microcontainers as stated in another article a few days ago to transport the virus and simply fill the microcontainers with h20?
I believe if you look into it you'll find that up until the dissolution of the former Soviet Union, the USSR continued to develop and use phage prophylaxis - that their work extended far beyond WWII and reached a level of considerable sophistication.
The economic disruptions of that time left the subject agencies and researchers without a budget, without salaries and, eventually, without the electrical power necessary to maintain what, by then, amounted to thousands of refined strains.
We're now in the unenviable position of retracing some of the work completed by them many years ago.
See brief article - Wired Oct 2003.
something to cure is being done
Não importa se há problemas com esta nova técnica.
A medicina trabalha com riscos, ensaios, testes,
sacrificios, e se no futuro, pessoas serão salvas,
vale a pena o sacrificio e os riscos no presente.
No matter if there are problems related with this new technique. The medicine works considering risks, attemptings, and sacrifices, and if in the future, persons will be cured, the sacrifices and
risks are totally worthwhile.
Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.
Our list of the 50 most innovative companies, including the following:
ekwhite
1 Comment
There are problems with this approach
One of the major problems with this approach is ensuring the virus does not mutate and cause more harm than good, by making a bacterial strain more virulent, rather than killing it.
Reply
kb1cvh@arrl.net
1 Comment
Re: There are problems with this approach
Phages are ubiquitous very simple viri. I do not perceive a risk of mutation deletirous to mammals being increased by using phages as antibacterial. Their target for millions of years has been bacteria.
Reply
gdp3
1 Comment
Re: There are problems with this approach
Ah, but phages are directly involved in the evolution of new pathogenic bacteria by the introduction of new genes ("horizontal transfer") ... examples include cholera toxin and shiga toxin (E. coli O157:H7). For an excellent overview see
Wagner & Waldor's 2002 paper "Bacteriophage control of bacterial virulence" [Infection and Immunity 70(8):3985-3993].
PubMed Central link
Reply